Ketorolac Tromethamine Injection — FDA Drug Shortage

Current — Baxter Healthcare

The FDA lists a drug shortage record for Ketorolac Tromethamine Injection (injection) from Baxter Healthcare with status Current. The shortage was first posted on Jun 6, 2018. Reported reason: Demand increase for the drug

Shortage details

Status
Current
Company
Baxter Healthcare
Package NDC
0338-0069-10
Dosage Form
Injection
Presentation
Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10)
Initial Posting
Jun 6, 2018

Reason

Demand increase for the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.